S&P 500 7,431.46 ▲ 37.16 (+0.50%) DOW 51,202.26 ▲ 353.46 (+0.70%) NASDAQ 25,888.84 ▲ 79.14 (+0.31%) US Markets Closed â€ĸ 06:13 AM ET

STME

STIMCELL ENERGETICS INC.

Price Chart
Latest Quote

$0.35

-0.00 (-0.44%)
Current Price
Previous Close $0.35
Open $0.29
Day High $0.29
Day Low $0.29
Volume 1,435
Fetched: 2026-06-15T10:13:07
Stock Information
Shares Outstanding 21.14M
Total Debt $769K
Cash Equivalents $10K
Net Income $-885K
Sector Healthcare
Industry Medical Devices
Market Cap $7.34M
EPS (TTM) $-0.04
Exchange OQB
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$8.10M
Income$-885K
Book/sh$-0.08
Cash/sh$0.00
Financial Ratios
Quick Ratio0.01
Current Ratio0.02
Returns & Margins
ROA-2153.11%
Ownership
Insider Ownership71.67%
Insider & Institutional transactions data not available
Valuation Ratios
Forward P/E-17.37
P/B-4.34
Analyst Data
Recommendationnone
Technical Indicators
SMA20$0.33
SMA50$0.32
SMA200$0.35
RSI97.44
ATR0.0043
Shares Float5.91M
Volatility44.83
Rel Volume1.78
Performance History
Week-0.44%
Month+16.95%
Quarter+15.75%
6 Months+5.26%
YTD-13.16%
Year-27.62%
3 Years+1097.76%
5 Years+24.05%
10 Years+24.05%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-12 $0.35 200
2026-06-11 $0.35 0
2026-06-10 $0.35 0
2026-06-09 $0.35 0
2026-06-08 $0.35 0
2026-06-05 $0.35 0
2026-06-04 $0.35 0
2026-06-03 $0.35 0
2026-06-02 $0.35 0
2026-06-01 $0.35 0
2026-05-29 $0.35 0
2026-05-28 $0.35 1,000
2026-05-27 $0.32 500
2026-05-26 $0.29 208
2026-05-22 $0.29 100
2026-05-21 $0.29 0
2026-05-20 $0.29 0
2026-05-19 $0.29 0
2026-05-18 $0.29 242
2026-05-15 $0.30 0
2026-05-14 $0.30 0
2026-05-13 $0.30 0
About STIMCELL ENERGETICS INC.

StimCell Energetics Inc., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions in the United States. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. The company also develops eBalance Home and eBalance Pro System for temporary relief of shoulder, waist, back, neck, arms, and legs. The company was formerly known as Cell MedX Corp. and changed its name to StimCell Energetics Inc. in November 2024. StimCell Energetics Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.

📰 Latest News
No news articles available at the moment. Check back later for updates on STME.
Period:
Loading...
Income Statement (Annual)
Metric 2025-05-31 2024-05-31 2023-05-31 2022-05-31
Revenue
Total Revenue $0 $0 $2,762 $6,065
Operating Revenue $0 $0 $2,762 $6,065
Reconciled Cost Of Revenue - $0 $2,279 $2,032
Cost Of Revenue - $0 $2,279 $2,032
Expenses
Interest Expense $38,256 $61,651 - -
Total Expenses $504,949 $261,270 $450,420 $677,758
Other Income Expense $-23,088 $180,435 - -
Net Non Operating Interest Income Expense $-38,256 $-61,651 $-47,384 $-25,686
Total Other Finance Cost $38,256 $61,651 $47,384 $25,686
Interest Expense Non Operating $38,256 $61,651 - -
Operating Expense $504,949 $261,270 $448,141 $675,726
Other Operating Expenses $90,000 $37,500 - -
General And Administrative Expense $350,940 $246,309 $358,921 $523,872
Selling And Marketing Expense - - - $0
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-566,293 $-142,486 $-495,042 $-697,379
Net Interest Income $-38,256 $-61,651 $-47,384 $-25,686
Normalized Income $-543,205 $-322,921 $-495,042 $-697,379
Net Income From Continuing And Discontinued Operation $-566,293 $-142,486 $-495,042 $-697,379
Net Income Common Stockholders $-566,293 $-142,486 $-495,042 $-697,379
Net Income $-566,293 $-142,486 $-495,042 $-697,379
Net Income Including Noncontrolling Interests $-566,293 $-142,486 $-495,042 $-697,379
Net Income Continuous Operations $-566,293 $-142,486 $-495,042 $-697,379
Pretax Income $-566,293 $-142,486 $-495,042 $-697,379
Special Income Charges $-5,931 $187,517 $0 $0
Operating Income $-504,949 $-261,270 $-447,658 $-671,693
Gross Profit - $0 $483 $4,033
Depreciation Amortization Depletion Income Statement - - $0 $1,145
Depreciation And Amortization In Income Statement - - $0 $1,145
Depreciation Income Statement - - $0 $1,145
Per Share
Diluted EPS $-0.03 $-0.01 $-0.15 $-0.15
Basic EPS $-0.03 $-0.01 $-0.15 $-0.15
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-504,949 $-261,270 $-447,658 $-670,548
Total Unusual Items $-23,088 $180,435 $0 $0
Total Unusual Items Excluding Goodwill $-23,088 $180,435 $0 $0
EBITDA (Bullshit earnings) $-528,037 $-80,835 $-447,658 $-670,548
EBIT $-528,037 $-80,835 $-447,658 $-671,693
Diluted Average Shares $19,843,258 $10,733,896 $4,194,870 $4,186,587
Basic Average Shares $19,843,258 $10,733,896 $4,194,870 $4,186,587
Diluted NI Availto Com Stockholders $-566,293 $-142,486 $-495,042 $-697,379
Other Special Charges $5,931 $-187,517 - -
Gain On Sale Of Security $-17,157 $-7,082 - -
Research And Development $64,009 $-22,539 $89,220 $150,709
Selling General And Administration $350,940 $246,309 $358,921 $523,872
Other Gand A $350,940 $246,309 $358,921 $523,872
Reconciled Depreciation - - $0 $1,145
Write Off - - - $0
Fetched: 2026-02-02
Balance Sheet (Annual)
Metric 2025-05-31 2024-05-31 2023-05-31 2022-05-31
Assets
Net Tangible Assets $-1,246,286 $-826,455 $-2,385,480 $-2,009,031
Total Assets $21,222 $46,122 $103,270 $41,344
Total Non Current Assets $0 $0 $0 $0
Current Assets $21,222 $46,122 $103,270 $41,344
Other Current Assets $6,641 $2,707 - -
Cash Cash Equivalents And Short Term Investments $14,581 $43,415 $98,295 $24,380
Cash And Cash Equivalents $14,581 $43,415 $98,295 $24,380
Cash Financial $14,581 $43,415 $98,295 $24,380
Prepaid Assets - $900 $1,750 $8,189
Receivables - $1,807 $3,225 $8,775
Taxes Receivable - $1,807 $3,225 $8,775
Inventory - - - -
Debt
Net Debt $444,391 $270,075 $902,729 $592,401
Total Debt $458,972 $313,490 $1,001,024 $616,781
Current Debt And Capital Lease Obligation $458,972 $313,490 $1,001,024 $616,781
Current Debt $458,972 $313,490 $1,001,024 $616,781
Other Current Borrowings $458,972 $313,490 $835,415 $505,893
Liabilities
Total Liabilities Net Minority Interest $1,267,508 $872,577 $2,488,750 $2,050,375
Total Non Current Liabilities Net Minority Interest $0 $0 $0 $0
Current Liabilities $1,267,508 $872,577 $2,488,750 $2,050,375
Payables And Accrued Expenses $808,536 $559,087 $1,487,726 $1,433,594
Payables $781,582 $531,029 $1,451,166 $1,404,717
Accounts Payable $322,144 $288,891 $408,264 $442,439
Current Notes Payable - $0 $165,609 $110,888
Equity
Common Stock Equity $-1,246,286 $-826,455 $-2,385,480 $-2,009,031
Total Equity Gross Minority Interest $-1,246,286 $-826,455 $-2,385,480 $-2,009,031
Stockholders Equity $-1,246,286 $-826,455 $-2,385,480 $-2,009,031
Gains Losses Not Affecting Retained Earnings $448,538 $435,491 $431,673 $313,080
Other Equity Adjustments $448,538 $435,491 $431,673 $313,080
Retained Earnings $-10,861,556 $-10,295,263 $-10,152,777 $-9,657,735
Other
Ordinary Shares Number $20,141,272 $19,815,758 $4,194,870 $4,194,870
Share Issued $20,141,272 $19,815,758 $4,194,870 $4,194,870
Tangible Book Value $-1,246,286 $-826,455 $-2,385,480 $-2,009,031
Invested Capital $-787,314 $-512,965 $-1,384,456 $-1,392,250
Working Capital $-1,246,286 $-826,455 $-2,385,480 $-2,009,031
Total Capitalization $-1,246,286 $-826,455 $-2,385,480 $-2,009,031
Additional Paid In Capital $9,146,591 $9,013,501 $7,272,701 $7,272,701
Capital Stock $20,141 $19,816 $62,923 $62,923
Common Stock $20,141 $19,816 $62,923 $62,923
Current Accrued Expenses $26,954 $28,058 $36,560 $28,877
Dueto Related Parties Current $459,438 $242,138 $1,042,902 $962,278
Net PPE - - - $0
Gross PPE - - - $0
Other Properties - - - -
Machinery Furniture Equipment - - - -
Fetched: 2026-02-02
Cash Flow Statement (Annual)
Metric 2025-05-31 2024-05-31 2023-05-31 2022-05-31
Free Cash Flow
Free Cash Flow $-141,600 $-145,898 $-272,209 $-450,591
Operating Activities
Operating Cash Flow $-141,600 $-145,898 $-272,209 $-450,591
Cash Flow From Continuing Operating Activities $-141,600 $-145,898 $-272,209 $-450,591
Operating Gains Losses $21,272 $-181,137 $71,141 $44,906
Investing Activities
Investing Cash Flow - - - $0
Cash Flow From Continuing Investing Activities - - - $0
Capital Expenditure - - - -
Financing Activities
Financing Cash Flow $112,858 $91,033 $346,364 $453,971
Cash Flow From Continuing Financing Activities $112,858 $91,033 $346,364 $453,971
Net Other Financing Charges - $75,000 - $160,000
Other
Issuance Of Debt $112,858 $16,033 $346,364 $293,971
End Cash Position $14,581 $43,415 $98,295 $24,380
Beginning Cash Position $43,415 $98,295 $24,380 $20,753
Effect Of Exchange Rate Changes $-92 $-15 $-240 $247
Changes In Cash $-28,742 $-54,865 $74,155 $3,380
Net Issuance Payments Of Debt $112,858 $16,033 $346,364 $293,971
Net Long Term Debt Issuance $112,858 $16,033 $346,364 $293,971
Long Term Debt Issuance $112,858 $16,033 $346,364 $293,971
Change In Working Capital $257,415 $116,074 $104,308 $137,976
Change In Other Current Assets $-3,930 $2,278 $11,408 $12,210
Change In Payables And Accrued Expense $261,345 $113,796 $92,900 $125,766
Change In Accrued Expense $-1,108 $-8,500 $7,770 $-6,302
Change In Payable $262,453 $122,296 $85,130 $132,068
Change In Account Payable $42,857 $46,750 $-14,064 $19,953
Other Non Cash Items $146,006 $61,651 $47,384 $62,761
Net Foreign Currency Exchange Gain Loss $15,341 $6,380 $71,141 $44,906
Net Income From Continuing Operations $-566,293 $-142,486 $-495,042 $-697,379
Depreciation Amortization Depletion - - $0 $1,145
Depreciation And Amortization - - $0 $1,145
Depreciation - - $0 $1,145
Net PPE Purchase And Sale - - - $0
Purchase Of PPE - - - $0
Change In Inventory - - - $0
Asset Impairment Charge - - - $0
Amortization Cash Flow - - - -
Amortization Of Intangibles - - - -
Fetched: 2026-02-02